This result indicated that the methylation of KLRB1 was a most pronounced decrease in Liver hepatocellular carcinoma (LIHC), Colon adenocarcinoma (COAD), and Prostate adenocarcinoma (PRAD) (Figure 1F). This evidence concerns the gene KLRB1 and prostate adenocarcinoma.